# Richard E. Champlin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-e-champlin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 77,552 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 148 |
| i10-index | 803 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5048913229 |
| ORCID iD | https://orcid.org/0000-0002-4314-5037 |
| Works | 2,079 |

## Researcher papers

- [Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture](https://scholariq.org/papers/cord-blood-engraftment-with-ex-vivo-mesenchymal-cell-coculture/)
- [Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation](https://scholariq.org/papers/indications-for-autologous-and-allogeneic-hematopoietic-cell-transplantation/)
- [Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial](https://scholariq.org/papers/lenalidomide-in-combination-with-rituximab-for-patients-with-relapsed-or/)
- [Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation](https://scholariq.org/papers/clinical-outcomes-and-prognostic-factors-in-patients-with-richter-s-syndrome/)
- [Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma](https://scholariq.org/papers/phase-i-study-of-cord-blood-derived-natural-killer-cells-combined-with/)
- [Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity](https://scholariq.org/papers/antigen-presenting-cell-mediated-expansion-of-human-umbilical-cord-blood-yields/)
- [Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy](https://scholariq.org/papers/standardizing-definitions-of-hematopoietic-recovery-graft-rejection-graft/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.